Metabolic Bone Disease (Archived)
Activity
Large Group Session
Large Group Session
A background to metabolic bone disease with a focus on Osteoporosis. Properties of trabecular bone. Properties of cortical bone. Remodelling enables bone to respond to mechanical and metabolic demands. RANK Ligand is the primary mediator of bone resportion. RANK Ligand is required for osteoclast formation, function and survival. OPG (Osteoprotegerin) is the endogenous inhibitor of the action of RANK Ligand (decoy receptor). The RANK Ligand : OPG ratio is a critical determinant of BMD.
Curriculum Block
Musculoskeletal Medicine / Part 4
- Indicates most relevant
Tags
Archived
Archived
Basic Sciences
Epidemiology
Pharmacology
Therapy
Cohort Year
2010
Curriculum Block
Musculoskeletal Medicine
Part 4
Curriculum Week
Part 4
Discipline
Orthopedics
Rheumatology
MeSH
Bone and Bones [A02.835.232]
Bone Development [G11.427.590.560.100]
Bone Diseases, Metabolic [C05.116.198]
Bone Resorption [C05.116.264]
Calcium, Dietary [D01.146.315]
Diphosphonates [D02.705.206]
Drug Therapy [E02.319]
Exercise Therapy [E02.779.483]
Fractures, Bone [C26.404]
Hormone Replacement Therapy [E02.319.452]
Musculoskeletal System [A02]
Osteoclasts [A11.329.372.700]
Osteogenesis [G11.427.590.560.100.729]
Osteoporosis [C05.116.198.579]
Quality of Life [I01.800]
RANK Ligand [D12.644.276.374.750.562]
Selective Estrogen Receptor Modulators [D06.347.360.827]
Vitamin D Deficiency [C18.654.521.500.133.770]